Of note in this connection, the pharmacological inhibition or genetic deletion of GBA2 causing a marked reduction of GlcChol has been found to ameliorate disease manifestations in NPC mice [53]. The gene discussed is GBA2; the disease is nasopharyngeal carcinoma.